Arthritis in Systemic Sclerosis: Systematic Review of the Literature and Suggestions for the Performance of Future Clinical Trials in Systemic Sclerosis Arthritis

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 6, 2012, Pages 801-814

  Clements, Philip J ^a   Allanore, Yannick ^b   Khanna, Dinesh ^c   Singh, Minjit ^d   Furst, Daniel E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d Rochester General Health System   (United States)

Author keywords

Arthritis in systemic sclerosis; Function; Musculoskeletal involvement in systemic sclerosis; Quality of life; Scleroderma; Systemic sclerosis

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY;

ARTHRITIS; ARTICLE; BONE RADIOGRAPHY; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONSTRUCT VALIDITY; CONTENT VALIDITY; CONTROLLED CLINICAL TRIAL (TOPIC); CONVERGENT VALIDITY; CRITERION RELATED VALIDITY; DISEASE ACTIVITY; DISEASE SEVERITY; DIVERGENT VALIDITY; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FACE VALIDITY; FUNCTIONAL ASSESSMENT; HAND FUNCTION; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MEDICAL LITERATURE; METHODOLOGY; MUSCULOSKELETAL PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; SHORT FORM 36; SYSTEMATIC REVIEW; SYSTEMIC SCLEROSIS; VALIDITY;

ARTHRITIS; CLINICAL TRIALS AS TOPIC; HUMANS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 84861223472     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.10.003     Document Type: Article

References (59)

1. Blocka K.L., Bassett L.W., Furst D.E., Clements P.J., Paulus H.E. The arthropathy of advanced progressive systemic sclerosis. A radiographic survey. Arthritis Rheum 1981, 24(7):874-884.
2. Baron M., Lee P., Keystone E.C. The articular manifestations of progressive systemic sclerosis (scleroderma). Ann Rheum Dis 1982, 41(2):147-152.
3. Steen V.D. Clinical manifestations of systemic sclerosis. Semin Cutan Med Surg 1998, 17(1):48-54.
4. LaMontagna, Baruffo A., Tirri R., Buono G., Valentini G. Foot involvement in systemic sclerosis: a longitudinal study of 100 patients. Semin Arthritis Rheum 2002, 31(4):248-255.
5. La Montagna G., Sodano A., Capurro V., Malesci D., Valentini G. The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study. Skeletal Radiol 2005, 34(1):35-41.
6. Ostojić P., Damjanov N. Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clin Rheumatol 2006, 25(4):453-457.
7. Malcarne V.L., Hansdottir I., McKinney A., Upchurch R., Greenbergs H.L., Henstorf G.H., et al. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol 2007, 34(2):359-367.
8. Ingegnoli F., Galbiati V., Zeni S., Meani L., Zahalkova L., Lubatti C., et al. Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. Clin Rheumatol 2007, 26(4):510-514.
9. Rannou F., Poiraudeau S., Berezné A., Baubet T., Le-Guern V., Cabane J., et al. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale. Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form. Health Survey Arthritis Rheum 2007, 57(1):94-102.
10. Erre G.L., Marongiu A., Fenu P., Faedda R., Masala A., Sanna M., et al. The "sclerodermic hand": a radiological and clinical study. Joint Bone Spine 2008, 75(4):426-431.
11. Ostojic P., Damjanov N. Indices of the Scleroderma Assessment Questionnaire (SAQ) can be used to demonstrate change in patients with systemic sclerosis over time. Joint Bone Spine 2008, 75(3):286-290.
12. Mouthon L., Rannou F., Bérezné A., Pagnoux C., Guilpain P., Goldwasser F., et al. Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey. Arthritis Rheum 2008, 59(7):968-973.
13. Richards H.L., Herrick A.L., Griffin K., Gwilliam P.D.H., Loukes J., Fortune D.G. Systemic sclerosis: patients' perceptions of their condition. Arthritis Care Res 2003, 49:689-696.
14. Sandqvist G., Eklund M., Akesson A., Nordenskiöld U. Daily activities and hand function in women with scleroderma. Scand J Rheumatol 2004, 33(2):102-107.
15. Brower L.M., Poole J.L. Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum 2004, 51(5):805-809.
16. Steen V.D., Medsger T.A. The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis. Arthritis Rheum 1997, 40(6):1146-1151.
17. Khanna P.P., Furst D.E., Clements P.J., Maranian P., Indulkar L., Khanna D. Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial. Rheumatology (Oxford) 2010, 49(5):955-959. D-Penicillamine Investigators.
18. Avouac J., Guerini H., Wipff J., Assous N., Chevrot A., Kahan A., et al. Radiological hand involvement in systemic sclerosis. Ann Rheum Dis 2006, 65(8):1088-1092.
19. Bassett L.W., Blocka K.L., Furst D.E., Clements P.J., Gold R.H. Skeletal findings in progressive systemic sclerosis (scleroderma). AJR Am J Roentgenol 1981, 136(6):1121-1126.
20. Brun B., Serup J., Hagdrup H. Radiological changes of the hands in systemic sclerosis. Acta Derm Venereol 1983, 63(4):349-352.
21. Allanore Y., Seror R., Chevrot A., Kahan A., Drapé J.L. Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis. Arthritis Rheum 2007, 56(8):2747-2754.
22. Low A.H., Lax M., Johnson S.R., Lee P. Magnetic resonance imaging of the hand in systemic sclerosis. J Rheumatol 2009, 36(5):961-964.
23. Cuomo G., Zappia M., Abignano G., Iudici M., Rotondo A., Valentini G. Ultrasonographic features of the hand and wrist in systemic sclerosis. Rheumatology (Oxford) 2009, 48(11):1414-1417.
24. Koutaissoff S., Vanthuyne M., Smith V., De Langhe E., Depresseux G., Westhovens R., et al. Hand radiological damage in systemic sclerosis: comparison with a control group and clinical and functional correlations. Semin Arthritis Rheum 2011, 40(5):455-460.
25. Morita Y., Muro Y., Sugiura K., Tomita Y. Anti-cyclic citrullinated peptide antibody in systemic sclerosis. Clin Exp Rheumatol 2008, 26(4):542-547.
26. Santiago M., Baron M., Miyachi K., Fritzler M.J., Abu-Hakima M., Leclercq S., et al. A Comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clin Rheumatol 2008, 27(1):77-83.
27. Johnson S.R., Glaman D.D., Schentag C.T., Lee P. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol 2006, 33(6):1117-1122.
28. Wolfe F., Clauw D.J., Fitzcharles M.A., Goldenberg D.L., Katz R.S., Mease P., et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010, 62:600-610.
29. Merkel P.A., Clements P.J., Reveille J.D., Suarez-Almazor M.E., Valentini G., Furst D.E. Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol 2003, 30(7):1630-1647. OMERACT 6.
30. Clements P.J., Furst D.E., Wong W.K., Mayes M., White B., Wigley F., et al. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 1999, 42(6):1194-1203.
31. Khanna D., Clements P.J., Furst D.E., Korn J.H., Ellman M., Rothfield N., et al. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2009, 60(4):1102-1111. Relaxin Investigators and the Scleroderma Clinical Trials Consortium.
32. Su T.I., Khanna D., Furst D.E., Danovitch G., Burger C., Maranian P., et al. Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot study. Arthritis Rheum 2009, 60(12):3821-3830.
33. Au K., Mayes M.D., Maranian P., Clements P.J., Khanna D., Steen V.D., et al. Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study. Arthritis Care Res (Hoboken) 2010, 62:1772-1778.
34. Nacci F., Righi A., Conforti M.L., Miniati I., Fiori G., Martinovic D., et al. Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study. Ann Rheum Dis 2007, 66(7):977-979.
35. Clements P.J., Wong W.K., Hurwitz E.L., Furst D.E., Mayes M., White B., et al. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum 2001, 42(11):2372-2380.
36. Avouac J., Walker U., Tyndall A., Kahan A., Matucci-Cerinic M. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol 2010, 37(7):1488-1501.
37. Medsger T.A., Silman A.J., Steen V.D., Black C.M., Akesson A., Bacon P.A., et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999, 26(10):2159-2167.
38. Clements P.J., Hurwitz E.L., Wong W.K., Seibold J.R., Mayes M., White B., et al. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 2000, 43(11):2445-2454.
39. Torok K.S., Baker N.A., Lucas M., Domsic R.T., Boudreau R., Medsger T.A. Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis. Clin Exp Rheumatol 2010, 28(2 Suppl 58):S28-S36.
40. Jacobsen S., Halberg P., Ullman S., Van Venrooij W.J., Høier-Madsen M., Wiik A., et al. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol 1998, 37(1):39-45.
41. Steen V.D. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005, 35(1):35-42.
42. Sandqvist G., Eklund M. Hand Mobility in Scleroderma (HAMIS) test: the reliability of a novel hand function test. Arthritis Care Res 2000, 13(6):369-374.
43. Sandqvist G., Eklund M. Validity of HAMIS: a test of hand mobility in scleroderma. Arthritis Care Res 2000, 13(6):382-387.
44. Sandqvist G., Eklund M. Hand Mobility in Scleroderma (HAMIS) test: the reliability of a novel hand function test. Arthritis Care Res 2000, 13(6):369-374.
45. Bongi S.M., Del Rosso A., Galluccio F., Sigismondi F., Miniati I., Conforti M.L., et al. Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis. Clin Rheumatol 2009, 28(10):1167-1173.
46. Duruöz M.T., Poiraudeau S., Fermanian J., Menkes C.J., Amor B., Dougados M., et al. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 1996, 23(7):1167-1172.
47. Poole J.L., Brower L. Validity of the scleroderma functional assessment questionnaire. J Rheumatol 2004, 31(2):402-403.
48. Serednicka K., Smyth A.E., Black C.M., Denton C.P. Using a self-reported functional score to assess disease progression in systemic sclerosis. Rheumatology (Oxford) 2007, 46(7):1107-1110.
49. Poole J.L., Gallegos M., O'Line S. Reliability and validity of the Arthritis Hand Function Test in adults with systemic sclerosis (scleroderma). Arthritis Care Res 2000, 13:69-73.
50. Backman C., Mackie H. Arthritis Hand Function Test: Inter-rater reliability among self-trained raters. Arthritis Care Res 1995, 6:10-15.
51. Steen V.D., Medsger T.A. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997, 40(11):1984-1991.
52. Ruof J., Bruhlmann P., Michel B.A., Stucki G. Development and validation of a self-administered systemic sclerosis questionnaire (SySQ). Rheumatology (Oxford) 1999, 38(6):535-542.
53. Ostojic P., Damjanov N. The scleroderma Assessment Questionnaire (SAQ). A new self-assessment questionnaire for evaluation of disease status in patients with systemic sclerosis. Z Rheumatol 2006, 65(2):168-175.
54. Khanna D., Yan X., Tashkin D.P., Furst D.E., Elashoff R., Roth M.D., et al. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum 2007, 56(5):1676-1684. Scleroderma Lung Study Group.
55. Hyphantis T.N., Tsifetaki N., Siafaka V., Voulgari P.V., Pappa C., Bai M., et al. The impact of psychological functioning upon systemic sclerosis patients' quality of life. Semin Arthritis Rheum 2007, 37(2):81-92.
56. Tashkin D.P., Elashoff R., Clements P.J., Goldin J., Roth M.D., Furst D.E., et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006, 354(25):2655-2666. Scleroderma Lung Study Research Group.
57. Avouac J., Mogavero G., Guerini H., Drapé J.L., Mathieu A., Kahan A., et al. Predictive factors of hand radiographic lesions in systemic sclerosis: a prospective study. Ann Rheum Dis 2011, 70:630-633.
58. Chitale S., Ciapetti A., Hodgson R., Grainger A., O'Connor P., Goodson N.J., et al. Magnetic resonance imaging and musculoskeletal ultrasonography detect and characterize covert inflammatory arthropathy in systemic sclerosis patients with arthralgia. Rheumatology (Oxford) 2010, 49(12):2357-2361.
59. Valentini G., Della R.A., Bombardieri S., Bencivelli W., Silman A.J., D'Angelo S., et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001, 60(6):592-599.